BridgeBio have substantially improved its progress of a novel solution for amyloid heart disease, employing the investigational drug. Preliminary patient results suggests promising benefits for patients diagnosed by https://biotech017909.ka-blogs.com/95671607/bridgebio-progresses-cardiac-amyloidosis-treatment-using-attruby